Patent ID: 11904049
Assignee: KLARIA PHARMA HOLDING AB
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A film suitable for administration to an oral cavity comprising:
(i) an alginate salt of a monovalent cation or a mixture of alginate salts containing at least one alginate salt of a monovalent cation; and
(ii) an active pharmaceutical ingredient (API) which is naloxone, a 3-O-ester derivative of naloxone, a 3-O-carbamyl derivative of naloxone, or a pharmaceutically acceptable salt thereof;
wherein the film is configured to achieve a peak plasma concentration of naloxone in a patient greater than 1 ng/mL within 60 minutes from adhesion of the film to the mucosa of the oral cavity.